| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| POINT Biopharma Global Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 0 | 27 Dec 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465923129768-demers-william-l-2023-12-27 | POINT Biopharma Global Inc. | 27 Dec 2023 | 4 | $0 | 4 | Chief Financial Officer | 27 Dec 2023, 17:36 |
| /report/000110465923039347-demers-william-l-2023-03-28 | POINT Biopharma Global Inc. | 28 Mar 2023 | 1 | $0 | 4 | Chief Financial Officer | 30 Mar 2023, 20:04 |
| /report/000110465922041126-demers-william-l-2022-03-29 | POINT Biopharma Global Inc. | 29 Mar 2022 | 1 | $0 | 4 | Chief Financial Officer | 31 Mar 2022, 16:58 |
| /report/000110465921090255-demers-william-l-2021-07-06 | POINT Biopharma Global Inc. | 06 Jul 2021 | 1 | $0 | 4 | Chief Financial Officer | 08 Jul 2021, 16:36 |
| /report/000110465921087825-demers-william-l-2021-06-30 | POINT Biopharma Global Inc. | 30 Jun 2021 | 1 | $0 | 4 | Chief Financial Officer | 30 Jun 2021, 21:26 |
| /report/000110465921087807-demers-william-l-2021-06-30 | POINT Biopharma Global Inc. | 30 Jun 2021 | 0 | $0 | 3 | Chief Financial Officer | 30 Jun 2021, 21:17 |